CELCUITY INC. (CELC) Current Ratio
- Current ratio · latest quarter: Value 8.93×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 8.93× | Current assets / current liabilities. $775.84M ÷ $86.87M ≈ 8.93× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 775.84M USD | Assets, Current |
| Current obligations | 86.87M USD | Liabilities, Current |
| Cash and equivalents | 182.05M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | (m) | |
| Inventory | (m) | |
| Payables | 8.09M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $775.84M | $86.87M | $182.05M | (m) | (m) | (m) | $8.09M | (m) | 8.93× |
| 2026-03-31 | $408.93M | $33.21M | $145.19M | (m) | (m) | (m) | $10.45M | (m) | 12.31× |
| 2025-12-31 | $465.66M | $44.15M | $165.70M | (m) | (m) | (m) | $6.41M | (m) | 10.55× |
| 2025-09-30 | $475.50M | $38.79M | $74.25M | (m) | (m) | (m) | $11.42M | (m) | 12.26× |
| 2025-06-30 | $183.10M | $39.94M | $46.35M | (m) | (m) | (m) | $11.16M | (m) | 4.58× |
| 2025-03-31 | $217.60M | $32.92M | $16.48M | (m) | (m) | (m) | $9.93M | (m) | 6.61× |
| 2024-12-31 | $244.57M | $31.72M | $22.52M | (m) | (m) | (m) | $9.37M | (m) | 7.71× |
| 2024-09-30 | $272.44M | $26.31M | $12.60M | (m) | (m) | (m) | $9.16M | (m) | 10.36× |
| 2024-06-30 | $291.93M | $19.53M | $30.46M | (m) | (m) | (m) | $6.20M | (m) | 14.95× |
| 2024-03-31 | $187.52M | $16.70M | $31.21M | (m) | (m) | (m) | $5.28M | (m) | 11.23× |
| 2023-12-31 | $190.59M | $14.19M | $30.66M | (m) | (m) | (m) | $5.08M | (m) | 13.43× |
| 2023-09-30 | $141.71M | $12.71M | $25.76M | (m) | (m) | (m) | $5.63M | (m) | 11.15× |
| 2023-06-30 | $152.81M | $7.08M | $32.24M | (m) | (m) | (m) | $3.02M | (m) | 21.58× |
| 2023-03-31 | $164.10M | $5.81M | $33.64M | (m) | (m) | (m) | $2.57M | (m) | 28.26× |
| 2022-12-31 | $175.19M | $6.88M | $24.57M | (m) | (m) | (m) | $2.63M | (m) | 25.46× |
| 2022-09-30 | $64.69M | $6.65M | $57.48M | (m) | (m) | (m) | $3.17M | (m) | 9.74× |
| 2022-06-30 | $71.96M | $4.15M | $66.91M | (m) | (m) | (m) | $2.30M | (m) | 17.34× |
| 2022-03-31 | $79.44M | $3.55M | $78.30M | (m) | (m) | (m) | $2.14M | (m) | 22.37× |
| 2021-12-31 | $85.35M | $2.51M | $84.29M | (m) | (m) | (m) | $1.51M | (m) | 34.06× |
| 2021-09-30 | $91.18M | $2.82M | $90.37M | (m) | (m) | (m) | $1.75M | (m) | 32.30× |
| 2021-06-30 | $42.25M | $1.54M | $41.64M | (m) | (m) | (m) | $647.17K | (m) | 27.50× |
| 2021-03-31 | $35.71M | $1.17M | $34.94M | (m) | (m) | (m) | $318.21K | (m) | 30.51× |
| 2020-12-31 | $12.17M | $1.19M | $11.64M | (m) | (m) | (m) | $217.38K | (m) | 10.26× |
| 2020-09-30 | $14.01M | $1.04M | $13.70M | (m) | (m) | (m) | $83.13K | (m) | 13.54× |
| 2020-06-30 | $15.88M | $828.88K | $15.43M | (m) | (m) | (m) | $81.05K | (m) | 19.15× |
| 2020-03-31 | $17.44M | $864.95K | $16.85M | (m) | (m) | (m) | $68.10K | (m) | 20.16× |
| 2019-12-31 | $19.25M | $911.33K | $18.74M | (m) | (m) | (m) | $142.77K | (m) | 21.12× |
| 2019-09-30 | $20.61M | $912.09K | $16.27M | (m) | (m) | (m) | $198.18K | (m) | 22.60× |
| 2019-06-30 | $22.35M | $885.49K | $14.92M | (m) | (m) | (m) | $141.22K | (m) | 25.24× |
| 2019-03-31 | $23.76M | $882.15K | $14.72M | (m) | (m) | (m) | $208.92K | (m) | 26.94× |
| 2018-12-31 | $25.22M | $662.33K | $15.94M | (m) | (m) | (m) | $119.81K | (m) | 38.07× |
| 2018-09-30 | $23.16M | $960.61K | $3.81M | (m) | (m) | (m) | $177.69K | (m) | 24.11× |
| 2018-06-30 | $21.79M | $962.89K | $3.17M | (m) | (m) | (m) | $149.40K | (m) | 22.63× |
| 2018-03-31 | $23.33M | $783.03K | $2.57M | (m) | (m) | (m) | $130.04K | (m) | 29.79× |
| 2017-12-31 | $24.48M | $578.05K | $2.64M | (m) | (m) | (m) | $71.91K | (m) | 42.36× |
| 2017-09-30 | $32.87M | $336.45K | $32.30M | (m) | (m) | (m) | $34.86K | (m) | 97.71× |
| 2016-12-31 | $5.91M | $445.36K | $5.86M | (m) | (m) | (m) | $331.53K | (m) | 13.27× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |